Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukaemia of precursor B-cell origin

Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.

Bone marrow transplantation·2017

Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL.

Bone marrow transplantation·2015

The impact of improved JACIE standards on the care of related BM and PBSC donors.

Bone marrow transplantation·2014

Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD.

Bone marrow transplantation·2014

Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML.

Bone marrow transplantation·2014

Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study.

Bone marrow transplantation·2013

Novel RNA polymerase I and cyclin-dependent kinase combination therapy for the treatment of aggressive acute myeloid leukemia.

Leukemia·2026

Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy.

Leukemia·2026

Generation of a novel knock-in mouse line expressing oncogenic Kit D814V in the hematopoietic stem cell compartment as a preclinical model for systemic mastocytosis.

Leukemia·2026

KT-253, a highly potent and selective MDM2 protein degrader, eliminates malignant myelofibrosis stem/progenitor cells.

Leukemia·2026

Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

Leukemia·2026

Chronic myeloid leukemia in a global context: confirmatory findings and novel discoveries from a refined Japanese Cohort.

Leukemia·2026

Immune checkpoint inhibitors induced autoimmune haemolytic anemia in patients with malignant cancer.

The oncologist·2026

Checkpoint inhibitors and chronic comedications: A retrospective study on immune-related adverse events.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026

JAK Inhibitors in Refractory Idiopathic Uveitis or Associated With Immune-Mediated Inflammatory Diseases: A Multicenter Case Series and Literature Review of Real-World Clinical Practice.

Ocular immunology and inflammation·2026

IgG4-related kidney disease: treatment standard.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

Programmable Immunity: DNA Nanostructures in Cancer Immunotherapy.

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology·2026

Effectiveness of interleukin (IL)-23 and IL-12/23 inhibitors and factors associated with response in psoriatic arthritis with axial involvement: the APxis-IL12-23 study.

Scandinavian journal of rheumatology·2026

Related Experiment Videos

Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukaemia of precursor B-cell origin

Related Concept Videos

Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.

Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL.

The impact of improved JACIE standards on the care of related BM and PBSC donors.

Impact of extracorporeal photopheresis on skin scores and quality of life in patients with steroid-refractory chronic GVHD.

Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML.

Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study.

Novel RNA polymerase I and cyclin-dependent kinase combination therapy for the treatment of aggressive acute myeloid leukemia.

Measurable residual disease assessment as an early end point of treatment efficacy in acute myeloid leukemia: a multinational PETHEMA study of 2623 patients treated with intensive therapy.

Generation of a novel knock-in mouse line expressing oncogenic Kit D814V in the hematopoietic stem cell compartment as a preclinical model for systemic mastocytosis.

KT-253, a highly potent and selective MDM2 protein degrader, eliminates malignant myelofibrosis stem/progenitor cells.

Venetoclax-based therapy versus hypomethylating agents alone in unfit patients with newly diagnosed acute myeloid leukemia: a real-world study from the PETHEMA registry.

Chronic myeloid leukemia in a global context: confirmatory findings and novel discoveries from a refined Japanese Cohort.

Immune checkpoint inhibitors induced autoimmune haemolytic anemia in patients with malignant cancer.

Checkpoint inhibitors and chronic comedications: A retrospective study on immune-related adverse events.

JAK Inhibitors in Refractory Idiopathic Uveitis or Associated With Immune-Mediated Inflammatory Diseases: A Multicenter Case Series and Literature Review of Real-World Clinical Practice.

IgG4-related kidney disease: treatment standard.

Programmable Immunity: DNA Nanostructures in Cancer Immunotherapy.

Effectiveness of interleukin (IL)-23 and IL-12/23 inhibitors and factors associated with response in psoriatic arthritis with axial involvement: the APxis-IL12-23 study.

Related Experiment Videos

Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukaemia of precursor B-cell origin

Related Concept Videos

Related Articles